InvestorsHub Logo
icon url

rx7171

11/24/06 1:42 AM

#1146 RE: rmcint5442 #1145

Thanks RM

Your description of the two "virus" approaches is helpful.
I rather prefer the CEGE Onc Virus for its direct attack without having to involve the immune system.

Still not clear if Geron would receive any financial return with the Merck adenoviruse.

Bob